MPLT
MapLight Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.30B
P/E Ratio
—
EPS
$-4.41
Beta
—
52W High
$33.28
52W Low
$12.24
50-Day MA
$24.64
200-Day MA
$19.87
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About MapLight Therapeutics, Inc. Common Stock
MapLight Therapeutics, Inc. is a pioneering biotechnology firm focused on the development of innovative therapies for complex neurological and psychiatric disorders. Leveraging its proprietary platform, the company targets sophisticated biological pathways to deliver transformative treatment solutions aimed at significantly improving patient outcomes. With a strong commitment to scientific excellence and an advancing clinical pipeline, MapLight is strategically positioned to meet critical unmet medical needs, highlighting its potential as a key contributor in the rapidly evolving neurotherapeutics market.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-209.47M |
| Operating Margin | 0.00% |
| Return on Equity | -80.90% |
| Return on Assets | -49.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $10.41 |
| Price-to-Book | 2.54 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $42.62M |
| Float | $12.36M |
| % Insiders | 51.44% |
| % Institutions | 55.16% |
Historical Volatility
HV 10-Day
81.95%
HV 20-Day
94.75%
HV 30-Day
104.23%
HV 60-Day
83.85%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($36.00 target)
2
Strong Buy5
BuyMore HEALTHCARE Stocks
Data last updated: 5/19/2026